insights_auto
Why is BLRX down 3,80%?
Dive Deeperchevron_right
BLRX:NASDAQ
BioLine RX Ltd - ADR
2,20 $
arrow_downward
-3,80%(-0,087) 1D
7 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BLRX...
Open
2,28 $
High
2,37 $
Low
2,16 $
Mkt. cap
11,34 մլն
Avg. vol.
24,32 հզր
Volume
0,00
52-wk high
4,54 $
52-wk low
2,16 $
EPS
-0,49 $
Beta
1,61
Shares outstanding
4,98 մլն
No. of employees
22
Open
2,28 $
High
2,37 $
Low
2,16 $
Mkt. cap
11,34 մլն
Avg. vol.
24,32 հզր
Volume
0,00
52-wk high
4,54 $
52-wk low
2,16 $
EPS
-0,49 $
Beta
1,61
Shares outstanding
4,98 մլն
No. of employees
22
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 շաբաթ առաջ
BioLineRx (BLRX) Slides 6.54% to $2.43 as Small-Cap Biotech Faces Renewed Selling - Protective Put
www.dars.gov.et
·
1 ամիս առաջ
BLRX Q2 2026 Earnings: Net Loss of $0.77 per ADS With No Revenue Reported - Earnings Outlook Update
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR